Nu Skin Enterprises, Inc.
NYSE:NUSHousehold & Personal Products
+$0.13 today
- Market cap
- $188.38M
- Beta
- 0.95
- P/E (TTM)
- 4.5
- EPS (TTM)
- $1.13
- Dividend yield
- 4.70%
Volume 0.59M
Average 0.57M
NUS Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Nu Skin Enterprises, Inc.NYSE: NUS
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow turns negative
Q1 FY2026 investing cash flow was -$14.29M, compared with $181.54M a year earlier. Trailing-twelve-month investing cash flow was -$25.17M.
Context
- Investing cash flow amounted to 11.5% of revenue in FY2025, up 9.3 pp from a year earlier.
- Investing cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly investing cash flow holds near -$14.29M or moves back toward the trailing-twelve-month quarterly average of -$6.29M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 170.66M USD
- Year-over-year change
- +549.6%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 170.66M | +549.6% |
| FY2024 | 2024-12-31 | (37.96M) | +71.8% |
| FY2023 | 2023-12-31 | (134.5M) | -100.5% |
| FY2022 | 2022-12-31 | (67.08M) | +24.4% |
| FY2021 | 2021-12-31 | (88.73M) | — |
Investing Cash Flow vs competitors
How NUS compares with its peers on the latest reported figures
- NUS's LTM Mar 2026 investing cash flow of $25.17M is the 5th largest of the 8 companies compared; the peer median is $30.87M.
- Its year-over-year change of -116.5% is the lowest of 7, against a peer median of -16.8%.
- Investing cash flow amounts to 1.7% of revenue for NUS, versus a peer median of 2.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $81.19M | +8.8% | +59.2% | 14.9% | |
| LTM Apr 2026 | $60.03M | -12.0% | +17.6% | 2.5% | |
| LTM Dec 2025 | $34.43M | — | -52.4% | — | |
| LTM Mar 2026 | $30.87M | -51.9% | -1.6% | 5.9% | |
| LTM Mar 2026 | $25.17M | -116.5% | — | 1.7% | |
| LTM Mar 2026 | $15.14M | -36.2% | — | 1.7% | |
| LTM Mar 2026 | $7.9M | -21.6% | -51.1% | 3.0% | |
| LTM Mar 2026 | $5.68M | +131.1% | — | 0.9% | |
| Peer median (excluding NUS) | $30.87M | -16.8% | -1.6% | 2.7% | |
Competitors are the stored peer set for NUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 147.27M | 104.78M | 8.6M | (146.59M) | 160.2M |
| Depreciation & Amortization | 76.32M | 72.51M | 70.92M | 69.81M | 52.26M |
| Deferred Income Tax | 5.82M | (51.63M) | (18.09M) | (55.48M) | 20K |
| Stock-Based Compensation | 23.19M | 12.37M | 15.65M | 14.82M | 24.11M |
| Change in Working Capital | (193.62M) | (92.68M) | (81.68M) | (28.34M) | (69.62M) |
| Accounts Receivables | 20.22M | (11.45M) | (22.68M) | (7.76M) | 10.06M |
| Inventory | (95.32M) | 40.31M | (13.22M) | 30.32M | 11.89M |
| Accounts Payables | (13.28M) | 9.26M | (10.08M) | (7.29M) | (9.11M) |
| Other Working Capital | (105.24M) | (130.8M) | (35.7M) | (43.6M) | (82.45M) |
| Other Non-Cash Items | 82.6M | 62.71M | 123.25M | 257.52M | (86.69M) |
| Operating Cash Flow | 141.58M | 108.06M | 118.64M | 111.74M | 80.29M |
| Capital Expenditures | (68.62M) | (59.06M) | (58.49M) | (41.58M) | (34.28M) |
| Acquisitions (Net) | (18.96M) | 8.02M | (77.28M) | 0 | 0 |
| Purchases of Investments | (16.24M) | (13.96M) | (16.88M) | (14.76M) | 0 |
| Sales of Investments | 15.09M | 5.93M | 18.15M | 18.38M | 10.21M |
| Other Investing Activities | 0 | (8.02M) | 0 | 0 | 194.73M |
| Investing Cash Flow | (88.73M) | (67.08M) | (134.5M) | (37.96M) | 170.66M |
| Debt Repayment | 38.13M | 25.58M | 100M | (112.89M) | (170M) |
| Common Stock Issued | 0 | 0 | 4.56M | 0 | (1.91M) |
| Common Stock Repurchased | (80.42M) | (70.05M) | (13.01M) | (2.06M) | (20.04M) |
| Dividends Paid | (76.27M) | (77.02M) | (77.62M) | (11.93M) | (11.83M) |
| Other Financing Activities | 13.86M | 21.98M | (3.2M) | (6.3M) | 1.38M |
| Financing Cash Flow | (104.7M) | (99.5M) | 10.73M | (133.18M) | (202.4M) |
| Effect of Forex Changes | (11.24M) | (16.35M) | (3.54M) | (9.78M) | 3.2M |
| Net Change in Cash | (63.09M) | (74.87M) | (8.67M) | (69.17M) | 51.75M |
| Free Cash Flow | 72.97M | 49.01M | 60.15M | 70.16M | 46.01M |
Nu Skin Enterprises, Inc.
NYSE:NUS
Intrinsic Alpha fair value
Locked
Current Price
$3.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.